Cite
HARVARD Citation
Grössmann, N. et al. (2018). 21 Five years of EMA-approved systemic cancer therapies for solid tumours – a comparison of two thresholds for meaningful clinical benefit. BMJ evidence-based medicine. p. A9. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grössmann, N. et al. (2018). 21 Five years of EMA-approved systemic cancer therapies for solid tumours – a comparison of two thresholds for meaningful clinical benefit. BMJ evidence-based medicine. p. A9. [Online].